372 related articles for article (PubMed ID: 25155935)
21. Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy.
Hirai K; Yamada Y; Hayashi H; Tanaka M; Izumiya K; Suzuki M; Yoshizawa M; Moriwaki H; Akimoto T; Tsuji D; Inoue K; Itoh K
Thromb Res; 2015 May; 135(5):861-6. PubMed ID: 25747538
[TBL] [Abstract][Full Text] [Related]
22. Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation.
Li J; Yang W; Xie Z; Yu K; Chen Y; Cui K
BMC Cardiovasc Disord; 2018 May; 18(1):96. PubMed ID: 29776386
[TBL] [Abstract][Full Text] [Related]
23. Variability in CYP2C9 allele frequency: a pilot study of its predicted impact on warfarin response among healthy South and North Indians.
Nahar R; Deb R; Saxena R; Puri RD; Verma IC
Pharmacol Rep; 2013; 65(1):187-94. PubMed ID: 23563037
[TBL] [Abstract][Full Text] [Related]
24. Genotype and risk of major bleeding during warfarin treatment.
Kawai VK; Cunningham A; Vear SI; Van Driest SL; Oginni A; Xu H; Jiang M; Li C; Denny JC; Shaffer C; Bowton E; Gage BF; Ray WA; Roden DM; Stein CM
Pharmacogenomics; 2014 Dec; 15(16):1973-83. PubMed ID: 25521356
[TBL] [Abstract][Full Text] [Related]
25. A network meta-analysis of CYP2C9, CYP2C9 with VKORC1 and CYP2C9 with VKORC1 and CYP4F2 genotype-based warfarin dosing strategies compared to traditional.
Sridharan K; Sivaramakrishnan G
J Clin Pharm Ther; 2021 Jun; 46(3):640-648. PubMed ID: 33346393
[TBL] [Abstract][Full Text] [Related]
26. Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes.
Teichert M; Eijgelsheim M; Uitterlinden AG; Buhre PN; Hofman A; De Smet PA; Visser LE; Stricker BH
Pharmacogenet Genomics; 2011 Jan; 21(1):26-34. PubMed ID: 21063236
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.
Shalia KK; Doshi SM; Parikh S; Pawar PP; Divekar SS; Varma SP; Mehta R; Doctor T; Shah VK; Saranath D
J Assoc Physicians India; 2012 Dec; 60():34-8. PubMed ID: 23781667
[TBL] [Abstract][Full Text] [Related]
28. Genetic determinants of acenocoumarol and warfarin maintenance dose requirements in Slavic population: a potential role of CYP4F2 and GGCX polymorphisms.
Wypasek E; Branicka A; Awsiuk M; Sadowski J; Undas A
Thromb Res; 2014 Sep; 134(3):604-9. PubMed ID: 25042728
[TBL] [Abstract][Full Text] [Related]
29. An acenocoumarol dosing algorithm exploiting clinical and genetic factors in South Indian (Dravidian) population.
Krishna Kumar D; Shewade DG; Loriot MA; Beaune P; Sai Chandran BV; Balachander J; Adithan C
Eur J Clin Pharmacol; 2015 Feb; 71(2):173-81. PubMed ID: 25519826
[TBL] [Abstract][Full Text] [Related]
30. Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients.
Liang R; Li L; Li C; Gao Y; Liu W; Hu D; Sun Y
J Thromb Thrombolysis; 2012 Jul; 34(1):120-5. PubMed ID: 22528326
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.
Kudzi W; Ahorhorlu SY; Dzudzor B; Olayemi E; Nartey ET; Asmah RH
BMC Res Notes; 2016 Dec; 9(1):507. PubMed ID: 27938396
[TBL] [Abstract][Full Text] [Related]
32. The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery.
Tatarunas V; Lesauskaite V; Veikutiene A; Grybauskas P; Jakuska P; Jankauskiene L; Bartuseviciute R; Benetis R
J Thromb Thrombolysis; 2014; 37(2):177-85. PubMed ID: 23677510
[TBL] [Abstract][Full Text] [Related]
33. Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.
Özer M; Demirci Y; Hizel C; Sarikaya S; Karalti İ; Kaspar Ç; Alpan S; Genç E
Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):209-14. PubMed ID: 23061746
[TBL] [Abstract][Full Text] [Related]
34. A multi-factorial analysis of response to warfarin in a UK prospective cohort.
Bourgeois S; Jorgensen A; Zhang EJ; Hanson A; Gillman MS; Bumpstead S; Toh CH; Williamson P; Daly AK; Kamali F; Deloukas P; Pirmohamed M
Genome Med; 2016 Jan; 8(1):2. PubMed ID: 26739746
[TBL] [Abstract][Full Text] [Related]
35. Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients.
Choi JR; Kim JO; Kang DR; Yoon SA; Shin JY; Zhang X; Roh MO; Hong HJ; Wang YP; Jo KH; Lee KS; Yun HJ; Oh YS; Yoo KD; Jeon HG; Lee YS; Kang TS; Park HJ; Chung MW; Kang JH
J Hum Genet; 2011 Apr; 56(4):290-5. PubMed ID: 21326313
[TBL] [Abstract][Full Text] [Related]
36. Frequency of selected single nucleotide polymorphisms influencing the warfarin pharmacogenetics in Slovak population.
Krajčíová L; Petrovič R; Déžiová L; Chandoga J; Turčáni P
Eur J Haematol; 2014 Oct; 93(4):320-8. PubMed ID: 24750390
[TBL] [Abstract][Full Text] [Related]
37. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
Zhuang W; Wu D; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):13-7. PubMed ID: 24602724
[TBL] [Abstract][Full Text] [Related]
38. Diversity of pharmacogenomic variants affecting warfarin metabolism in Sri Lankans.
Ranasinghe P; Sirisena N; Senadeera V; Anandagoda G; Dissanayake VH
Pharmacogenomics; 2022 Nov; 23(17):917-923. PubMed ID: 36285665
[No Abstract] [Full Text] [Related]
39. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
Takeuchi F; McGinnis R; Bourgeois S; Barnes C; Eriksson N; Soranzo N; Whittaker P; Ranganath V; Kumanduri V; McLaren W; Holm L; Lindh J; Rane A; Wadelius M; Deloukas P
PLoS Genet; 2009 Mar; 5(3):e1000433. PubMed ID: 19300499
[TBL] [Abstract][Full Text] [Related]
40. Race influences warfarin dose changes associated with genetic factors.
Limdi NA; Brown TM; Yan Q; Thigpen JL; Shendre A; Liu N; Hill CE; Arnett DK; Beasley TM
Blood; 2015 Jul; 126(4):539-45. PubMed ID: 26024874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
